Lifecore Biomedical, Inc.
LFCR
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes andā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
29 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$8.04
Price-4.51%
-$0.38
1Y
Price
Market Cap
$300.798m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-22.9%
EBITDA Margin-32.1%
Net Profit Margin+0.1%
Free Cash Flow MarginRevenue
$135.271m
+5.0%
1y CAGR+9.9%
3y CAGR+5.6%
5y CAGREarnings
-$32.478m
+16.1%
1y CAGR-98.0%
3y CAGR-69.8%
5y CAGREPS
-$1.07
+15.8%
1y CAGR-119.7%
3y CAGR-85.7%
5y CAGRBook Value
$36.786m
$235.204m
Assets$198.418m
Liabilities$137.533m
DebtDebt to Assets
58.5%
-19.5x
Debt to EBITDAFree Cash Flow
-$9.561m
+29.8%
1y CAGR+36.0%
3y CAGR+33.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company